Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

87.9k citations
1.7k papers ·

Impact in

  • Pharmacology top 0.5%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Oncology top 5%
    • Drug Transport and Resistance Mechanisms

Papers in

    • Pharmacogenetics and Drug Metabolism 377
    • Inflammatory mediators and NSAID effects 61
    • Antibiotics Pharmacokinetics and Efficacy 52
    • Drug Transport and Resistance Mechanisms 272

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

1.5k papers receiving 77.8k citations

Peers

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
Comparison fields: 5 of 207
  • Pharmacology 23.2k
  • Oncology 23.8k
  • Pediatrics, Perinatology and Child Health 11.2k
  • Transplantation 1.5k
  • Pharmacology 6.1k
Replace GlaxoSmithKline (Netherlands) with:
GlaxoSmithKline (Netherlands) Netherlands
Slotervaartziekenhuis Netherlands
Pharmo Institute Netherlands
Ludwig Cancer Research Switzerland
de Duve Institute Belgium
UCB Pharma (Belgium) Belgium
Paris Cardiovascular Research Center France
Laboratoire d'études sur les monothéismes France
Daiichi Sankyo (Germany) Germany
Institute for Biomedicine Italy
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology relative to GlaxoSmithKline (Netherlands) Netherlands GlaxoSmithKline (Netherlands)'s profile →
Citations per field
00.5×8.3×
GlaxoSmithKline (Netherlands) · 1×
Citations per year

Countries citing scholars working at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology more than expected).

Fields of papers published by authors at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology at the time of their publication.

About Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

In recent decades, authors affiliated with Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology have published 1.7k papers, which have received a total of 87.9k indexed citations . Scholars at this organization have produced 410 papers in Pharmacology, 446 papers in Oncology, 172 papers in Pediatrics, Perinatology and Child Health, 143 papers in Pharmacology and 110 papers in Cancer Research on the topics of Pharmacogenetics and Drug Metabolism (377 papers), Drug Transport and Resistance Mechanisms (272 papers), Pharmacological Effects and Toxicity Studies (100 papers), Lymphoma Diagnosis and Treatment (88 papers), Estrogen and related hormone effects (72 papers), Inflammatory mediators and NSAID effects (61 papers), Analytical Chemistry and Chromatography (52 papers) and Antibiotics Pharmacokinetics and Efficacy (52 papers). Their work is cited by papers focused on Pharmacology (23.2k citations), Oncology (23.8k citations), Pediatrics, Perinatology and Child Health (11.2k citations), Transplantation (1.5k citations) and Pharmacology (6.1k citations). Authors at Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology collaborate with scholars in Germany, United States and Sweden and have published in prestigious journals including Clinical Pharmacology & Therapeutics, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Clinical Pharmacokinetics and Blood. Some of Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology's most productive authors include Matthias Schwab, Ulrich Klotz, Ulrich M. Zanger, Michel Eichelbaum, Martin F. Fromm, Kathrin Klein, Elke Schaeffeler, Eduard F. Stange, Jan Wehkamp and Oliver Burk.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact